Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Body size and risk of pre- and post-menopausal breast cancer in Taiwan.

Chie WC., Chen CF., Lee WC., Chen CJ.

Laboratory Study on Systemic / IV, published in Anticancer Res (1996) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Anticancer Res (1996)
Country
Greece
Reported sample size
—
Source database
PubMed
PMID
8920780

Abstract (original English)

The incidence of breast cancer is increasing rapidly in Taiwan but is still low compared with western countries. The impact of body size factors in western countries inspired us to have a case-control study. A matched case-control study was done on 122 pairs of incident cases of female breast cancer and community controls. Body height and weight were collected from a questionnaire interview and used to derive the body mass index (kg/m2). Demographic and reproductive characteristics were collected and controlled as potential confounders. Conditional multiple logistic regression analysis was used to estimate the multivariate-adjusted odds ratios for each risk factor regarding body size. After adjustment for age, schooling years, age at menarche and parity; body weight and height were positively related to postmenopausal breast cancer but not significantly related to the risk of premenopausal breast cancer. The odds ratios for body mass index were less prominent. Women with a higher breast stem cell mass resulting from better adolescent nutrition had a higher risk for breast cancer; and postmenopausal obesity may increase the breast cancer risk through the increased conversion of adrenal androstenedione to estrogen in adipose tissue after menopause.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Body HeightBody WeightBreast NeoplasmsCase-Control StudiesConfounding Factors, EpidemiologicFemaleHumansOdds RatioPostmenopausePremenopause

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research